02/26/2015 - 3:26pm
ACIP recommends use of meningococcal group B vaccines to vaccinate high-risk groups

The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.

02/26/2015 - 3:08pm
Researchers develop smartphone accessory to test for HIV, syphilis

A team of researchers at Columbia Engineering has developed a low-cost smartphone accessory that can perform a point-of-care test for HIV or syphilis in just 15 minutes.

 

02/26/2015 - 2:27pm
Chronic patients using digital technology to manage their disease feel 'healthier'

A survey found that chronic disease patients who use digital technology to manage their disease state feel "healthier."

 

02/26/2015 - 12:53pm
Sanofi's Toujeo injection product granted FDA approval

Sanofi expands its portfolio of insulin therapy products with the introduction of the once-daily, long-acting Toujeo. 

02/26/2015 - 12:03pm
Greenstone intros generic Tarka tabs

Greenstone, a subsidiary of Pfizer, announced the introduction of trandolapril/verapamil hydrochloride extended-release tablets to its line of generic pharmaceutical products. 

 

02/26/2015 - 11:43am
FDA approves antibacterial drug Avycaz

The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration. 

02/26/2015 - 11:36am
Diplomat Pharmacy extends specialty reach with BioRx acquisition

Diplomat Pharmacy on Thursday acquired the specialty pharmacy BioRx.

 

02/26/2015 - 11:29am
Cardinal Health, McKesson pick up on distribution of Flublok

Protein Sciences expanded Flublok distribution through Cardinal, McKesson this week. 

02/25/2015 - 12:12pm
Diplomat Pharmacy to dispense new multiple myeloma treatment

Diplomat Pharmacy to dispense new multiple myeloma treatment from Novartis. 

02/25/2015 - 11:45am
NCHS reports opioid analgesic use

In 10 years, the percentage of opioid analgesic users who used an opioid analgesic stronger than morphine increased from 17% to 37%, NCHS reported Wednesday.